Trademark: 85406129
Word
CONTINULOG
Status
Dead
Status Code
606
Status Date
Monday, November 12, 2012
Serial Number
85406129
Mark Type
4000
Filing Date
Wednesday, August 24, 2011
Published for Opposition
Tuesday, February 14, 2012
Abandoned Date
Monday, November 12, 2012

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants

Trademark Events
Nov 13, 2012
Abandonment Notice Mailed - No Use Statement Filed
Nov 12, 2012
Abandonment - No Use Statement Filed
Apr 10, 2012
Noa E-Mailed - Sou Required From Applicant
Feb 14, 2012
Official Gazette Publication Confirmation E-Mailed
Feb 14, 2012
Published For Opposition
Jan 25, 2012
Notification Of Notice Of Publication E-Mailed
Jan 10, 2012
Law Office Publication Review Completed
Jan 3, 2012
Assigned To Lie
Dec 13, 2011
Approved For Pub - Principal Register
Dec 13, 2011
Assigned To Examiner
Aug 31, 2011
New Application Office Supplied Data Entered In Tram
Aug 27, 2011
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24